NCT00297050View on ClinicalTrials.gov

Safety and Dose Study of Peramivir for Influenza Treatment

PHASE1CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 23, 2006

Primary Completion Date

November 14, 2006

Study Completion Date

November 14, 2006

Conditions
Influenza
Interventions
DRUG

Peramivir

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00297050 - Safety and Dose Study of Peramivir for Influenza Treatment | Biotech Hunter | Biotech Hunter